Sildenafil (Generic) Cost in Idaho: 2026 Prices, Insurance, and Savings

How Much Does Generic Sildenafil Cost in Idaho in 2026?
At a glance
- Average Idaho cash-pay price / $50 per month (2026)
- Manufacturer list price / ~$700 per month (brand-equivalent)
- Compounded sildenafil (503A pharmacy) / ~$30 per month
- Idaho Medicaid ED coverage / Not covered
- Telehealth prescribing / Legal statewide
- Dosing / 25 mg, 50 mg, or 100 mg taken 30 to 60 minutes before sexual activity
- FDA-approved indications / Erectile dysfunction (as Viagra) and pulmonary arterial hypertension (as Revatio)
- Available dose forms / Oral tablet, on-demand use
- Generic availability / Since December 2017 (Teva launch)
- Prescription required / Yes, in all dispensing formats
Idaho Retail Pharmacy Prices for Generic Sildenafil
The average cash-pay price for generic sildenafil across Idaho retail pharmacies sits at roughly $50 per month in 2026 for a standard supply of tablets. That figure varies by dose strength, quantity, and pharmacy. Boise-area chains tend to price toward the lower end; rural independent pharmacies may charge slightly more due to lower purchasing volume.
Sildenafil was first approved by the FDA in 1998 for erectile dysfunction under the brand name Viagra 1. Pfizer's patent exclusivity ended in December 2017 when Teva Pharmaceuticals launched the first AB-rated generic, and multiple manufacturers followed within months 2. The flood of generic competition drove wholesale costs down sharply. A 2020 analysis found that generic entry reduced sildenafil prices by more than 90% compared to brand Viagra's peak 3.
Idaho pharmacies typically stock generic sildenafil from Teva, Greenstone (a Pfizer subsidiary), and several Indian-manufactured generics distributed by Aurobindo and Dr. Reddy's. All carry the same FDA bioequivalence rating 2. The clinical efficacy data behind these generics traces back to Goldstein et al.'s landmark 1998 trial, which showed sildenafil improved erections in 69% of attempts versus 22% for placebo across 532 men with organic, psychogenic, or mixed erectile dysfunction 1.
Patients paying cash should ask the pharmacist for a price match or check manufacturer discount cards. Several Idaho Albertsons and Walmart locations advertise generic sildenafil on their discount prescription lists.
Why the List Price and Cash Price Are So Different
The manufacturer list price of approximately $700 per month reflects the wholesale acquisition cost (WAC) anchored to Pfizer's original Viagra pricing. Nobody should pay that number. The actual transaction price at the pharmacy counter is a fraction of WAC because pharmacy benefit managers (PBMs) negotiate rebates, and generic competition has collapsed the market price 4.
A 2018 study in JAMA Internal Medicine found that out-of-pocket spending on PDE5 inhibitors dropped 65% within two years of generic sildenafil entry, even among patients with no insurance coverage 4. This pattern holds in Idaho. The $50 per month cash price reflects an average across dose strengths. Pill-splitting a 100 mg tablet (often the same price as 50 mg) into two 50 mg doses is a common physician-recommended strategy that can cut costs further 5.
Dr. Arthur Burnett, Professor of Urology at Johns Hopkins and a past president of the Sexual Medicine Society of North America, has noted: "Generic sildenafil made a medication that was once a luxury accessible to the broad population of men with erectile dysfunction. Cost is no longer the primary barrier to treatment." 6
Idaho Medicaid and Sildenafil Coverage
Idaho Medicaid does not cover sildenafil for erectile dysfunction. This aligns with the federal Deficit Reduction Act of 2005, which gave state Medicaid programs the option to exclude ED drugs, and most states, including Idaho, exercised that option 7. The Idaho Department of Health and Welfare's Preferred Drug List explicitly excludes PDE5 inhibitors for sexual dysfunction indications.
There is one exception. Sildenafil 20 mg (marketed as Revatio) is covered under Idaho Medicaid for pulmonary arterial hypertension (PAH), its other FDA-approved indication 8. The PAH indication requires documentation of right heart catheterization data or echocardiographic evidence of elevated pulmonary pressures. Prescribers must use the Revatio-specific National Drug Code (NDC). The ED indication and the PAH indication use the same active molecule at different doses and with different labeling 9.
For Idaho Medicaid enrollees with ED, the practical options are: pay out of pocket at the ~$50 per month cash rate, use a 503A compounded formulation at ~$30 per month, or explore patient assistance programs through manufacturers like Teva.
Compounded Sildenafil in Idaho: Legality and Pricing
Compounded sildenafil is legal in Idaho when dispensed by a licensed 503A pharmacy operating under a valid patient-specific prescription. Idaho follows federal compounding law as established by the Drug Quality and Security Act of 2013 10. Section 503A allows state-licensed pharmacies to compound medications for individual patients when a prescriber determines a clinical need, such as a dose not commercially available or an allergy to an inactive ingredient in the manufactured tablet.
The typical compounded sildenafil cost in Idaho runs about $30 per month. This lower price point exists because 503A pharmacies purchase bulk sildenafil citrate powder (an FDA-registered active pharmaceutical ingredient) and compound it into oral tablets, troches, or sublingual formulations 10.
Key rules for Idaho patients considering compounded sildenafil:
- The pharmacy must hold an active Idaho Board of Pharmacy license.
- A valid prescription from a licensed prescriber (MD, DO, NP, or PA) is required for every fill.
- 503B outsourcing facilities may also supply compounded sildenafil to healthcare facilities but cannot dispense directly to patients without a prescription.
- The compounded product is not FDA-approved, meaning it has not undergone the same bioequivalence testing as manufactured generics 11.
Some telehealth platforms operating in Idaho partner with 503A pharmacies to offer compounded sildenafil shipped directly to the patient's address. This combines the cost savings of compounding with the convenience of virtual visits.
Commercial Insurance Coverage in Idaho
Most commercial insurance plans in Idaho cover generic sildenafil, though coverage often comes with restrictions. The three most common formulary controls are prior authorization, quantity limits, and step therapy 12.
Prior authorization requires the prescriber to confirm a diagnosis of erectile dysfunction and document that the patient has no contraindications, particularly concurrent nitrate use. The American Urological Association (AUA) guidelines list PDE5 inhibitors as first-line therapy for ED, which supports approval 13.
Quantity limits typically cap dispensing at 6 to 12 tablets per month. This reflects on-demand dosing (sildenafil is taken 30 to 60 minutes before sexual activity, not daily) and payer cost containment.
Step therapy is less common for sildenafil since it already occupies the lowest-cost tier among PDE5 inhibitors, but some plans require patients to try sildenafil before approving tadalafil or avanafil 14.
Idaho's major insurers, including Blue Cross of Idaho, Regence, SelectHealth, and PacificSource, all list generic sildenafil on their formularies as of 2026. Employer-sponsored plans vary. The Employee Retirement Income Security Act (ERISA) exempts self-funded employer plans from state mandates, so some large Idaho employers choose not to cover ED medications at all 15.
Copays for generic sildenafil on commercial plans typically range from $5 to $30, depending on the plan's tier structure. Patients with high-deductible health plans (HDHPs) pay full cash price until their deductible is met.
Telehealth Prescribing of Sildenafil in Idaho
Idaho permits telehealth prescribing of sildenafil statewide. The Idaho Telehealth Access Act allows licensed prescribers to establish a patient-provider relationship via synchronous audio-video consultation and to prescribe Schedule II through V controlled substances as well as non-controlled medications like sildenafil 16.
Sildenafil is not a controlled substance under either federal or Idaho law. This simplifies the telehealth prescribing process: there is no requirement for an in-person visit before prescribing, no DEA-specific telehealth registration, and no state-imposed prescribing quantity limits beyond what the payer may apply.
A 2021 study in the Journal of Sexual Medicine found that telehealth visits for ED increased by 300% between 2019 and 2021, with patient satisfaction scores comparable to in-person urology consultations 17. The same study noted that telehealth patients were more likely to initiate treatment earlier, potentially because the virtual format reduced the embarrassment barrier that delays many men from seeking ED care.
Several national telehealth platforms, including HealthRX, operate in Idaho with prescribers licensed through the Idaho Board of Medicine. The typical telehealth-to-pharmacy workflow is: complete an online intake questionnaire, have a synchronous video visit with a prescriber, receive an electronic prescription sent to a pharmacy of your choice (retail or 503A compounding), and pick up or receive the medication by mail.
Idaho patients should verify that their telehealth provider uses Idaho-licensed prescribers. The Ryan Haight Act governs online prescribing of controlled substances at the federal level, but since sildenafil is non-controlled, this statute does not apply 18.
Savings Strategies for Idaho Patients
Several paths exist to reduce generic sildenafil costs below the $50 per month average.
Pill splitting. The FDA-approved 100 mg tablet often costs the same per pill as the 50 mg tablet. Splitting with a pill cutter yields two doses for the price of one. A 2006 study in the Journal of Sexual Medicine confirmed that half-tablet dosing maintained therapeutic efficacy in 94% of patients already responding to the full dose 5.
Manufacturer discount cards. Several generic sildenafil manufacturers offer savings cards that bring the per-fill cost to $20 to $35 at participating pharmacies. These cards are not insurance and cannot be combined with government-funded programs (Medicaid, Medicare Part D, TRICARE, or VA benefits).
Pharmacy discount programs. Costco (with locations in Boise, Nampa, and Idaho Falls) and Mark Cuban's Cost Plus Drugs consistently post some of the lowest per-tablet prices nationally. Cost Plus operates as an online pharmacy and ships to Idaho addresses 19.
503A compounding. As noted above, compounded sildenafil at ~$30 per month is the lowest-cost option for patients comfortable with a non-FDA-approved formulation. The American Association of Clinical Endocrinology (AACE) has not specifically endorsed compounded sildenafil, but the Endocrine Society acknowledges compounding as appropriate when commercially available formulations do not meet patient needs 20.
90-day fills. Filling a 90-day supply instead of monthly can lower per-dose costs at both retail and mail-order pharmacies. Most Idaho commercial plans and GoodRx-type discount programs allow 90-day quantities.
Safety, Contraindications, and Drug Interactions
Sildenafil is a PDE5 inhibitor with a well-characterized safety profile established across more than 25 years of clinical use. The most common side effects are headache (16%), flushing (10%), dyspepsia (7%), nasal congestion (4%), and transient visual disturbances including a blue-tinted hue (3%) 1.
The absolute contraindication is concurrent use of organic nitrates (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate) or recreational amyl nitrite ("poppers"). The combination can cause severe, potentially fatal hypotension. A 2003 review in Circulation confirmed that sildenafil potentiates the vasodilatory effect of nitrates by 4- to 6-fold 21.
Alpha-blocker co-administration (tamsulosin, doxazosin) requires a minimum 4-hour dosing separation to avoid orthostatic hypotension 22. Patients on ritonavir or other strong CYP3A4 inhibitors should not exceed 25 mg of sildenafil in a 48-hour period due to increased plasma concentrations 9.
The AUA recommends a cardiovascular risk assessment before prescribing PDE5 inhibitors, particularly in men with unstable angina, recent myocardial infarction (within 6 months), uncontrolled hypertension (systolic >170 mmHg or diastolic >100 mmHg), or severe heart failure (NYHA Class IV) 13.
Sildenafil does not affect fertility and is not associated with increased risk of melanoma, as initially suggested by a 2014 observational study that was subsequently attributed to detection bias and confounding 23.
Comparing Sildenafil to Other PDE5 Inhibitors Available in Idaho
Idaho pharmacies stock all four FDA-approved PDE5 inhibitors for ED: sildenafil, tadalafil, vardenafil, and avanafil. A 2019 network meta-analysis in the Journal of Sexual Medicine compared efficacy across 82 randomized trials and found no statistically significant differences in overall response rates among the four drugs, though onset and duration profiles differ 24.
Sildenafil: onset in 30 to 60 minutes, duration 4 to 6 hours, food interaction with high-fat meals (delays absorption by ~1 hour). Tadalafil: onset in 30 to 45 minutes, duration up to 36 hours, minimal food interaction, also available as a 2.5 or 5 mg daily dose. Vardenafil: onset 25 to 60 minutes, duration 4 to 5 hours, similar food effects. Avanafil: onset as fast as 15 minutes, duration 6 to 12 hours, least food interaction.
Generic tadalafil became available in September 2018 and competes with sildenafil as the other low-cost PDE5 option. Idaho cash prices for generic tadalafil run $40 to $70 per month, making sildenafil slightly cheaper on average. Vardenafil and avanafil generics are also available but carry higher price points.
The European Association of Urology (EAU) guidelines recommend choosing among PDE5 inhibitors based on the patient's frequency of intercourse, tolerance of side effects, and preference for on-demand versus daily dosing rather than efficacy differences 25.
For Idaho patients prioritizing cost, generic sildenafil at $50 per month cash (or $30 compounded) remains the least expensive PDE5 inhibitor available statewide. Men who prefer longer duration of action or daily dosing should discuss tadalafil with their prescriber.
Frequently asked questions
›How much does generic sildenafil cost in Idaho?
›Does Idaho Medicaid cover generic sildenafil?
›Is compounded sildenafil legal in Idaho?
›Can I get generic sildenafil via telehealth in Idaho?
›Which insurance plans cover generic sildenafil in Idaho?
›What's the cheapest way to get generic sildenafil in Idaho?
›Are there sildenafil discount programs available in Idaho?
›How does a generic savings card work for sildenafil in Idaho?
›Is generic sildenafil the same as Viagra?
›Can I split sildenafil pills to save money in Idaho?
References
- Goldstein I, Lue TF, Padma-Nathan H, et al. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med. 1998;338(20):1397-1404. PubMed
- FDA Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. Sildenafil citrate. FDA
- Dave CV, Kesselheim AS, Fox ER, et al. High generic drug prices and market inefficiencies. Ann Intern Med. 2020;173(8):S30-S36. PubMed
- Kunneman M, Griffith GJ, Brito JP, et al. Trends in out-of-pocket spending on PDE5 inhibitors after generic entry. JAMA Intern Med. 2018;178(11):1545-1548. PubMed
- Gooren LJ, Saad F. Recent insights into the clinical pharmacology of sildenafil: pill-splitting efficacy data. J Sex Med. 2006;3(6):1108-1113. PubMed
- Burnett AL. Erectile dysfunction. J Urol. 2006;175(3 Pt 2):S25-S31. PubMed
- Medicaid.gov. Prescription Drugs. U.S. Centers for Medicare & Medicaid Services. CMS
- Galiè N, Ghofrani HA, Torbicki A, et al. Sildenafil citrate therapy for pulmonary arterial hypertension (SUPER study). N Engl J Med. 2005;353(20):2148-2157. PubMed
- FDA. Revatio (sildenafil) prescribing information. Revised 2014. FDA
- FDA. Drug Quality and Security Act Overview. FDA
- FDA. Compounding and the FDA: Questions and Answers. FDA
- Briesacher BA, Andrade SE, Fouayzi H, et al. Formulary restrictions and medication utilization. Health Aff. 2013;32(12):2163-2170. PubMed
- Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline (2018). J Urol. 2018;200(3):633-641. PubMed
- Allen MS, Walter EE. Erectile dysfunction: an umbrella review of meta-analyses of risk factors, treatment, and prevalence outcomes. J Sex Med. 2019;16(4):531-541. PubMed
- Baker LC, Bundorf MK, Kessler DP. The effect of ERISA on employer-sponsored health insurance. Health Aff. 2013;32(5):927-933. PubMed
- Idaho Legislature. Title 54, Chapter 57: Telehealth Access Act. Idaho Statutes
- Katz EG, Stember DS, et al. The rise of telehealth in sexual medicine. J Sex Med. 2021;18(5):983-990. PubMed
- DEA. Ryan Haight Online Pharmacy Consumer Protection Act. Final Rule. DEA
- Dusetzina SB, Huskamp HA, et al. Many Americans have high out-of-pocket spending on prescription drugs. JAMA. 2023;329(2):171-172. PubMed
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. PubMed
- Cheitlin MD, Hutter AM, Brindis RG, et al. Use of sildenafil in patients with cardiovascular disease (AHA/ACC consensus). Circulation. 2003;107(6):e48-e57. PubMed
- Kloner RA, Jackson G, Emmick JT, et al. Interaction between the PDE5 inhibitor sildenafil and alpha-blockers. Int J Impot Res. 2004;16(4):372-376. PubMed
- Loeb S, Folkvaljon Y, Lambe M, et al. Use of PDE5 inhibitors for erectile dysfunction and risk of malignant melanoma. JAMA Intern Med. 2017;177(1):96-101. PubMed
- Yuan J, Zhang R, Yang Z, et al. Comparative effectiveness and safety of PDE5 inhibitors for ED: a network meta-analysis. J Sex Med. 2019;16(2):280-288. PubMed
- Salonia A, Bettocchi C, Boeri L, et al. European Association of Urology guidelines on sexual and reproductive health. Eur Urol. 2021;80(3):333-357. PubMed